Cargando…

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by the accumulation of fibrillar collagens in the alveolar space resulting in reduced pulmonary function and a high mortality rate. Biomarkers measuring the turnover of type I and III collagen could provide valuable information for pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jessen, H., Hoyer, N., Prior, T. S., Frederiksen, P., Karsdal, M. A., Leeming, D. J., Bendstrup, E., Sand, J. M. B., Shaker, S. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281632/ https://www.ncbi.nlm.nih.gov/pubmed/34261485 http://dx.doi.org/10.1186/s12931-021-01801-0

Ejemplares similares

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Jessen, Henrik, et al.
Publicado: (2021)

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
por: Hoyer, Nils, et al.
Publicado: (2019)

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
por: Leeming, Diana J., et al.
Publicado: (2012)

Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis
por: Hesse, Christina, et al.
Publicado: (2022)

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2019)

Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2020)

LPA(1) antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis
por: Decato, Benjamin E., et al.
Publicado: (2022)

Biomarkers of collagen turnover are related to annual change in FEV(1) in patients with chronic obstructive pulmonary disease within the ECLIPSE study
por: Leeming, Diana J., et al.
Publicado: (2017)

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
por: Organ, Louise A., et al.
Publicado: (2019)

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis
por: Leeming, D.J., et al.
Publicado: (2018)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
por: Kehlet, S. N., et al.
Publicado: (2016)

Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2017)

Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor
por: Hansen, Niels Ulrik Brandt, et al.
Publicado: (2016)

Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment
por: Kølner-Augustson, Line, et al.
Publicado: (2020)

Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates
por: Hoyer, Nils, et al.
Publicado: (2022)

Collagen Type III and VI Turnover in Response to Long-Term Immobilization
por: Sun, Shu, et al.
Publicado: (2015)

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Accelerated extracellular matrix turnover during exacerbations of COPD
por: Sand, Jannie M. B., et al.
Publicado: (2015)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis
por: Brix, Ninna, et al.
Publicado: (2016)

Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
por: Bihlet, Asger Reinstrup, et al.
Publicado: (2017)

Circulating Levels of a Collagen Type V Propeptide Fragment in a Carbon Tetrachloride Reversible Model of Liver Fibrosis
por: Vassiliadis, E., et al.
Publicado: (2012)

Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL)
por: Lønsmann, Ida, et al.
Publicado: (2023)

Global incidence and prevalence of idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients
por: Genovese, Federica, et al.
Publicado: (2020)

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
por: Hyldgaard, Charlotte, et al.
Publicado: (2020)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Familial idiopathic pulmonary fibrosis in a young female
por: Sritharan, Sajitha S., et al.
Publicado: (2018)

PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
por: Kronborg-White, Sissel, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis vs. pulmonary involvement of collagen vascular disease: HRCT findings.
por: Lim, M. K., et al.
Publicado: (1997)

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Association of Versican Turnover with All-Cause Mortality in Patients on Haemodialysis
por: Genovese, Federica, et al.
Publicado: (2014)

Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis
por: Leeming, D. J., et al.
Publicado: (2021)

An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution
por: Pehrsson, Martin, et al.
Publicado: (2022)

Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis
por: Vassiliadis, Efstathios, et al.
Publicado: (2011)

Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2020)

Collagen turnover profiles in chronic kidney disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2019)

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
por: Nielsen, Mette J., et al.
Publicado: (2015)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bop6agkcv3sk43c1is7pgij2bt